Friday, February 07, 2020 1:13:30 PM
Geez why did I even ask, worse than trying to get a real answer from OGI.
First off are you saying their medical flower is different from their recreational flower. Secondly if its regulated so closely how did OGI sell tainted product which they have a class action law suit against them for. And also why the million dollars of returns last quarter. Or why are there links I posted of them selling ridiculously low quality flower.
It may be better regulated now when it comes pesticides or mold but the regulations have nothing to do with the THC level, freshness or humidity level which is a huge factor in the product selling.
First off are you saying their medical flower is different from their recreational flower. Secondly if its regulated so closely how did OGI sell tainted product which they have a class action law suit against them for. And also why the million dollars of returns last quarter. Or why are there links I posted of them selling ridiculously low quality flower.
It may be better regulated now when it comes pesticides or mold but the regulations have nothing to do with the THC level, freshness or humidity level which is a huge factor in the product selling.
Recent OGI News
- Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 04/17/2026 12:33:10 PM
- Organigram Closes Previously Announced Acquisition of Sanity Group, Private Placement Financing with BAT and ATB Senior Secured Credit Facilities • Business Wire • 04/15/2026 04:03:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/31/2026 01:55:58 AM
- Organigram Announces Shareholder Approval of Acquisition of Sanity Group GmbH and Results of its Annual General and Special Meeting • Business Wire • 03/31/2026 12:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/23/2026 02:10:09 PM
- Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH • Business Wire • 03/23/2026 10:00:00 AM
- Organigram Announces Mailing of Management Information Circular in Connection with Annual General and Special Meeting • Business Wire • 03/10/2026 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/09/2026 09:14:50 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/05/2026 05:27:39 PM
- Organigram Global Expands FAST™ Innovation Platform with SHRED Shotz, Leveraging SHRED Brand Equity • Business Wire • 03/05/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/03/2026 05:23:16 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/24/2026 04:18:03 PM
- Organigram Further Expands Global Portfolio with Launch of Edison and BOXHOT Medical Vapes and Pastilles in Australia • Business Wire • 02/24/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/20/2026 09:58:07 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/19/2026 07:21:54 PM
- Organigram Announces C$65.2 Million BAT Private Placement Investment in Connection with the Acquisition of Sanity Group • Business Wire • 02/19/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/18/2026 03:40:13 PM
- Organigram Announces Proposed Acquisition of Sanity Group, a Leading German Cannabis Company • Business Wire • 02/18/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/10/2026 12:41:44 PM
- Organigram Reports First Quarter Fiscal 2026 Results • Business Wire • 02/10/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/03/2026 04:10:05 PM
- Organigram to Report First Quarter Fiscal 2026 Results on February 10, 2026 • Business Wire • 02/03/2026 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/31/2025 02:49:11 PM
- Organigram Extends Innovation Investment with Phylos • Business Wire • 12/31/2025 11:00:00 AM
